Recombinant adenovirus-p53 gene therapy combined with transcatheter arterial chemoembolization for p53-positive and p53-negative hepatocellular carcinoma

Chinese Journal of Interventional Imaging and Therapy

Volumn 7, Issue 4, 2010, Pages 354-357

  Ou, Sheng Qiu ^a   Ma, Yi Long ^a   Kang, Ping ^a   Li, Zhi Kun ^a   Meng, Zhi Bin ^a   Qi, Feng ^a  

^a Department of Interventional Therapy   (China)

Author keywords

Adenovirus, human; Carcinoma, hepatocellular; Embolization, therapeutic; Gene therapy; Genes, p53; Vascular endothelial growth factor A

Indexed keywords

ADENOVIRUS VECTOR; PROTEIN P53; VASCULOTROPIN;

ADVANCED CANCER; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GENE THERAPY; CHEMOEMBOLIZATION; CONTROL GROUP; DRUG EFFICACY; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE;

EID: 84860504245     PISSN: 16728475     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. 2005, 13(1): 125-127.
2. 2004, 3(11): 11-14.
3. 2005, 2(6): 405-408.
4. 2007, 24(1): 14-16.
5. 2003, 32(1): 20-24.
6. Calmarini C M, Kamath K, Caniter-Viornery A, et al. Drug resistance associated with loss of p53 involves extensive alterations in microtubule composition and dynamics. Br J Cancer, 2003, 88(11): 1793-1799.
7. Ding H F, Lin Y L, Mecill C, et al. Essential role forcaspase-8 in transcription-independent apoptosis triggered by p53. J Biol Chem, 2000, 275(49): 38905-38911.
8. Roth J A, Gramer S F. Gene replacement therapy for nonsmall cell lung cancer: a review. Hematol Oncol Clin North Am, 2004, 18(1): 215-229.
9. 2004, 1(2): 151-154.
10. Lawler J, Miao W M, Duquette M, et al. Thrombospondin-1 gene expression affects survival and tumor spectrum of p53-deficient mice. Am J Pathol, 2001, 159(5): 1949-1956.
11. Fujisawa T, Watanabe J, Kamata Y, et al. VEGF expression and its reguration by p53 gene transfection in endometrial carcinoma cells. Hum Cell, 2003, 16(1): 47-54.
12. 2003: 91-161.